Prostate-specific Antigen Testing in England Shows Concerning Patterns of Overuse
A study of over 10 million men reveals frequent testing of patients unlikely to benefit, raising questions about current screening practices.
A study of over 10 million men reveals frequent testing of patients unlikely to benefit, raising questions about current screening practices.
A new study validated a urine test that offers a less invasive, more accurate alternative to traditional prostate cancer screening.
A newly discovered class of RNA molecules in extracellular vesicles could serve as biomarkers for non-invasive cancer diagnosis.
A study investigating a single invitation to a PSA blood test to screen for prostate cancer found it had a small impact on reducing deaths.
Read MoreMRI of the prostate, combined with a blood test, can help find if a prostate lesion is clinically significant cancer, new research suggests.
Read MoreResearchers developed a deep-learning model to improve the 3D segmentation of glandular tissue structures for prostate cancer assessment.
Read MoreAI has helped scientists reveal a new form of aggressive prostate cancer which could revolutionize how the disease is diagnosed in the future.Â
Read MoreOncobiomix says it will use Limmi’s Disease Insights Platform to power their AI models for predicting prostate cancer risk.
Read MorePathologists at OSUCCC-James have been evaluating an AI algorithm for the past year. The results are extremely promising.
Read MoreA new study has found that rectal examination has no advantages over the PSA blood test for detecting prostate cancer.
Read MoreResearchers have developed a blood test that can reliably detect NEPC and differentiate it from CRPC-adenocarcinoma.
Read MoreArteraAI says the CMS decided on the payment rate for the ArteraAI Prostate Test, a clinical diagnostic laboratory test for prostate cancer.
Read MoreUCLA Researchers have received a five-year, $3 million grant to develop AI that can detect and predict aggressive prostate cancer.
Read MoreMen with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.Â
Read MoreBlack men are more likely to develop prostate cancer than white men and more likely to have advanced disease and to die than white men.Â
Read MoreArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read MoreResearchers developed a patent-pending method and algorithm to predict prostate cancer recurrence in patients treated by radiation therapy.Â
Read MoreBlack patients seen by a precision medicine navigator were substantially more likely to receive genomic testing than those who were not.
Read More